Compare AU

Compare CURE vs. JRHG

Compare shares and ETFs on the ASX that you can trade on Pearler.

Global X S&P Biotech ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are CURE and JRHG. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.

Community Stats

CURE

JRHG

Popularity

Low

N/A

Pearlers invested

80

0

Median incremental investment

$620.00

$0

Median investment frequency

Monthly

N/A

Median total investment

$1,296.12

$0

Average age group

> 35

N/A


Key Summary

CURE

JRHG

Strategy

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

JRHG.AX was created on 2023-11-16 by JPMorgan. The fund's investment portfolio concentrates primarily on total market equity.

Top 3 holdings

AbbVie Inc (2.62 %)

Alnylam Pharmaceuticals Inc (2.59 %)

Amgen Inc (2.59 %)

Jpmorgan Gl Re En In Eqh Active ETF (Managed Fund) (100 %)

Top 3 industries

Health Care (100.00 %)

Other (10.24 %)

Top 3 countries

United States (97.17 %)

Switzerland (1.51 %)

United Kingdom of Great Britain and Northern Ireland (1.16 %)

Management fee

0.45 %

0.3 %


Key Summary

CURE

JRHG

Issuer

Global X

JPMorgan

Tracking index

S&P Biotechnology Select Industry

MSCI World ex Australia - AUD - Benchmark TR Net Hedged

Asset class

ETF

ETF

Management fee

0.45 %

0.3 %

Price

$49.01

$65.91

Size

$36.111 million

N/A

10Y return

N/A

N/A

Annual distribution/ dividend yield (5Y)

4.24 %

0.14 %

Market

ASX

ASX

First listed date

12/11/2018

15/11/2023

Purchase fee

$6.50

$6.50


Community Stats

CURE

JRHG

Popularity

Low

N/A

Pearlers invested

80

0

Median incremental investment

$620.00

$0

Median investment frequency

Monthly

N/A

Median total investment

$1,296.12

$0

Average age group

> 35

N/A


Pros and Cons

CURE

JRHG

Pros

  • Higher exposure to US market

  • Higher distribution yield

  • Lower management fee

  • Higher price growth

Cons

  • Higher management fee

  • Lower price growth

  • Lower exposure to US market

  • Lower distribution yield

CURE

JRHG

Higher exposure to US market

Lower exposure to US market

Higher management fee

Lower management fee

Lower price growth

Higher price growth

Higher distribution yield

Lower distribution yield

Home